2025-07-14 - Analysis Report
Okay, here's an analysis of Merck & Co Inc (MRK) based on the provided data, presented in English with key figures first, followed by interpretation:

## MRK (Merck & Co Inc) Analysis

Merck & Co Inc is a global pharmaceutical company focused on discovering, developing, manufacturing, and marketing a wide range of healthcare products.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** -0.0401889217763518 (-4.02%)
*   **VOO Cumulative Return:** 95.46151685210242 (95.46%)
*   **Deviation (MRK - VOO):** -95.5
*   **Deviation Range:** Max: 23.1, Min: -99.5
*   **Relative Deviation:** 3.3

**Analysis:** MRK has significantly underperformed the S&P 500 (VOO) over the tracked period.  The -95.5% deviation shows a substantial gap in cumulative returns. A relative deviation of 3.3 indicates that MRK's underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
| ---------- | ------- | ----- | ------- | ------ | ------ |
| 2015-2017  | 5.0%    | 58.2% | -24.0%  | -0.0   | 134.8  |
| 2016-2018  | 43.0%   | 66.4% | 25.0%   | -0.1   | 183.1  |
| 2017-2019  | 40.0%   | 66.4% | 11.0%   | 0.3    | 217.9  |
| 2018-2020  | 20.0%   | 66.4% | 0.0%    | 0.3    | 196.0  |
| 2019-2021  | -1.0%   | 65.6% | -50.0%  | 0.3    | 192.4  |
| 2020-2022  | 13.0%   | 69.5% | 11.0%   | 0.3    | 278.6  |
| 2021-2023  | 31.0%   | 69.5% | 13.0%   | 0.3    | 273.8  |
| 2022-2024  | -7.0%   | 69.5% | -33.0%  | 0.2    | 249.8  |
| 2023-2025  | -52.0%  | 61.4% | -99.0%  | 0.5    | 209.3  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Performance has varied significantly over different periods. The most recent period (2023-2025) shows a steep decline.
*   **MDD (Maximum Drawdown):** High MDD values indicate significant risk and volatility.
*   **Alpha:**  Alpha is generally negative, particularly in recent periods (2019-2021, 2022-2024, 2023-2025), suggesting underperformance relative to a benchmark.
*   **Beta:** Beta values are low, indicating MRK is less sensitive to market movements.  The recent increase to 0.5 suggests increasing sensitivity to market fluctuations.
*   **Cap(B) (Market Capitalization in Billions):** Market cap has fluctuated.

### 2. Recent Stock Price Movement

*   **Current Price:** 83.36
*   **Last Market Data:** Price: 84.0727, Previous Close: 83.36, Change: 0.85
*   **5-Day Moving Average:** 82.672
*   **20-Day Moving Average:** 80.8174
*   **60-Day Moving Average:** 79.4456

**Analysis:** The stock price is above all its short-term and mid-term moving averages, indicating a recent upward trend. The Last-market data shows a noticeable positive change, meaning the price has significantly increased.

### 3. Technical Indicators

*   **MRI (Market Risk Indicator):** 0.3294 (Low Risk)
*   **RSI (Relative Strength Index):** 70.3263940772608
*   **PPO (Percentage Price Oscillator):** 0.469
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.33)
*   **20-Day Relative Deviation Change:** 3.0 (+) (Short-term increase)
*   **Expected Return (%):** -317.1 (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates low market risk for MRK at the moment.
*   **RSI:**  RSI is above 70, suggesting the stock may be overbought in the short term.
*   **PPO:**  A positive PPO suggests the stock is in an uptrend.
*   **Hybrid Signal:** The signal recommends a buy with caution, indicating some risk but also potential upside.
*   **20-Day Relative Deviation Change:**  The recent increase suggests a short-term recovery relative to the S&P 500, but it's not enough to offset the overall underperformance.
*   **Expected Return:** The extremely negative expected return is alarming, implying significant underperformance compared to the S&P 500 over the long term if the current trend continues.

### 4. Recent News & Significant Events

*   **2025-07-14:** Major business developments, regulatory changes, or market events impacting MRK.
*   **2025-07-13:** Analysts discussing recent performance and outlook, considering industry trends and global economic factors.
*   **2025-07-10:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-12:** Market experts highlighting both risks and opportunities.

**Analysis:** Recent news suggests that MRK is experiencing volatility and is subject to significant market events, regulatory changes, or business developments. Analysts are actively discussing the company's performance and outlook, emphasizing both opportunities and risks. Investors should closely monitor company announcements and news.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
| ---------- | ---- | ----------- |
| 2025-05-02 | 2.01 | 15.53 B$    |
| 2024-11-06 | 1.25 | 16.66 B$    |
| 2024-08-05 | 2.15 | 16.11 B$    |
| 2024-05-03 | 1.88 | 15.78 B$    |
| 2025-05-02 | 1.88 | 15.78 B$    |

**Analysis:**
*   **EPS (Earnings Per Share):** EPS has fluctuated over the past year, with a peak in 2024-08-05. Recent data from 2025-05-02 shows a moderate EPS.
*   **Revenue:** Revenue has also seen variations, with a high point in 2024-11-06. Recent revenue figures are slightly lower than previous highs.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-03-31   | $15.53B   | 77.98%        |
| 2024-12-31   | $15.62B   | 75.50%        |
| 2024-09-30   | $16.66B   | 75.51%        |
| 2024-06-30   | $16.11B   | 76.76%        |
| 2024-03-31   | $15.78B   | 77.56%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| ------------ | --------- | --------- |
| 2025-03-31   | $48.34B   | 10.51%    |
| 2024-12-31   | $46.31B   | 8.08%     |
| 2024-09-30   | $44.50B   | 7.09%     |
| 2024-06-30   | $43.58B   | 12.52%    |
| 2024-03-31   | $40.36B   | 11.80%    |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable over the past year, with some quarterly fluctuations.
*   **Profit Margin:** Profit margins are high and consistent, indicating strong profitability.
*   **Equity:** Equity has generally increased over the past year, showing growth in the company's net assets.
*   **ROE (Return on Equity):** ROE has fluctuated, with the highest value in 2024-06-30. Recent ROE is moderate.

### 7. Overall Analysis

MRK's performance has been concerning, significantly underperforming the S&P 500. While recent price action shows a short-term upward trend, the negative expected return and recent negative alpha values suggest potential challenges. The high profit margins and stable revenue indicate a strong underlying business, but recent news about business developments, regulatory changes, and market volatility suggests that MRK is facing significant uncertainty. Recent volatility suggests potential short-term opportunities, but caution is warranted. The hybrid signal also reflects this mix of opportunity and risk.

**Recommendation:** Given the mixed signals, investors should exercise caution and conduct further research into the specific factors driving the recent negative performance and market volatility before making any investment decisions.
